TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Percent change in osteoclast maturation and activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in number of TRAP cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in bone mass density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in bone turnover markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medium- to long-term Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Visual Analogue Scale (10-point Likert scale)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Oxford Shoulder Score (OSS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Short Form-12 (SF-12)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Geometric Mean Titer (GMT) for Pertussis Toxoid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean change in RVEF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of successful abortion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume as measured by the Heartfelt-1 device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Asymptomatic patients with an IgG response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality of life measured by Glasgow Benefit Inventory
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of days absent
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Early loco-regional recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Harvested lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Blood glucose variability (LBGI-HBGI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: abdominal pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cholate Shunt Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anti-HBs seroprotection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Response to booster
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of patients with at least 50% improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ItchyQoL (TotsItchyQoL) test-retest reliability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ItchyQoL (KidsItchyQoL) test-retest reliability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ItchyQoL (TotsItchyQoL) validity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ItchyQoL (KidsItchyQoL) validity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cocaine use/cravings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of gene transfer
Endpoint domain: Adverse events/effects
Primary endpoint: Annualised Asthma Exacerbation Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Improvement in memory or thinking
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percent of Subjects With Testosterone Levels in the Normal Range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Clinical Response of Cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of dose limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse events of oral LCL161
Endpoint domain: Adverse events/effects
Primary endpoint: Number and rate of patients with confirmed recurrent VTE and VTE-related death
Endpoint domain: Mortality/survival
Primary endpoint: Number and rate of major Bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: Area under plasma concentration-time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutrophil Engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Clinical Global Impression - Severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum Tolerated Dose (MTD) / Recommended Phase 2 Dose (RP2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalized Liver Enzyme Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excess tissue volume evolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference of female condom by type
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Antral follicle count accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: minimum amount of peanut protein causing clinical reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified Rankin Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Accuracy of clinical probability assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Clinical Grading of Skin Dryness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Bone mineral density Z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exosomes quantity excreted from the epicardial fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in brain functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain at rest and when coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nutrition Risk in the Critically Ill (NUTRIC) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of responses to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained Virologic Response (SVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Virologic Response (VR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sustained Biochemical Response (SBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of pain rating - change of TCP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diabetes related distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety of chemotherapy plus bevacizumab
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of administering treatment
Endpoint domain: Resource use
Primary endpoint: Fugl Meyer Assessment of Motor Recovery following Stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 9 Hole Peg Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ablation success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Live birth Rate
Endpoint domain: Mortality/survival
Primary endpoint: Retention in care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 24 hour diurnal IOP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Number of Patients With Remission of Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of patients with intraoperative or postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Changes of Modified Gingival Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time spent with over or under-inflation of the tracheal cuff
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Post-operative pulmonary complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Primary Sclerosing Cholangitis Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: complete recovery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Child Urine Cotinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cigarettes/Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants accurately dated by TCD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Atrial fibrillation event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total Sign Score (TSS) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelial t-PA Release in Response to Bradykinin (BDK)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Holmes and Rahe Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Waisman Activities of Daily Living Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Temple University Community Participation (TUCP) measure
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: myocardial infarct size (myocardial salvage index %)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Successful remission rate
Endpoint domain: Mortality/survival
Primary endpoint: Chest wall motion amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma AUX-I and AUX-II Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Investigator CR-PCSS Rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Investigator CR-PCSS Change From Baseline
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Amount of maxillary advancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of definite stent thrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: accurate diagnosis of acute appendicitis in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreasing incidence of negative appendectomy
Endpoint domain: Adverse events/effects
Primary endpoint: decreasing number of readmitted cases with diagnosis of acute appendicitis
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Skin testing results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pharyngeal Residue Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Plasma Concentration (Cmax) of fluticasone propionate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC) of fluticasone propionate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of SC12267 in combination with methotrexate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from time zero to last quantifiable concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom distress Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Fatigue symptom inventory
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: The SF-12 health survey
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of Serious or Device Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Insulin resistance (HOMA-IR) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Weight loss rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bleeding loss at Day 5 after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pediatric Quality of Life Inventory
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of Participants Experiencing Treatment Emergent Oral Adverse Events on or Before 14 Days of Use
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants Experiencing Treatment Emergent Oral Adverse Events on or Before 7 Days of Use
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants That Were Seizure-free
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: response after 72 h of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability and Safety
Endpoint domain: Adverse events/effects
Primary endpoint: Patients With ≥ VGPR (Very Good Partial Response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of constipation symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Body length compared to normal pediatric growth curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in scores of standardized developmental assessments (Vineland & Batelle)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Body Weight compared to normal pediatric growth curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Head circumference compared to normal pediatric growth curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in brachial artery flow mediated dilation (FMD%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in forearm microvascular reperfusion rate (%/sec)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in total 6-minute walking distance (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relapse of Psychotic Symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: recurrent PE and fatal PE
Endpoint domain: Mortality/survival
Primary endpoint: Local Tumor Progression Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Time to Local Progression
Endpoint domain: Mortality/survival
Primary endpoint: Implant Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Implant Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of paroxystic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NASH CRN score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Time to adjudicated Composite Clinical Outcome event
Endpoint domain: Mortality/survival
Primary endpoint: Change in Pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of hypocalcemic subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage change in time spent OUTSIDE of therapeutic range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of first acute myeloid leukemia relapse
Endpoint domain: Mortality/survival
Primary endpoint: Rate of invasive bacterial infections
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in knowledge about Fetal Alcohol Syndrome (FAS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in alcohol consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adoption of the intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants With a Clinical Cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to generation of OncoPanel Report
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completely wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Disease-specific health status improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: improvement of dysphagia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response Rate (Complete and Partial)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Knee flexion and extension range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of spontaneous abortion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Recurrent pregnancy loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Clotting time of ROTEM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clot firmness time of ROTEM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alpha angle of ROTEM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum clot firmness of ROTEM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month systolic blood pressure (SBP) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of hospitalization attributable to RSV
Endpoint domain: Mortality/survival
Primary endpoint: Headache Impact Test 6 (HIT-6)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Daily Headache and Pain Log
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mechanical-Visual Analogue Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absolute risk of tooth sensibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment success defined by negative donor specific crossmatch or elimination of donor specific antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percentage of time glucose level between 70-119 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Lesions That Changed in Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Abundance of antimicrobial Staph colonies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of Successful Block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Vital Status of Heart Transplant Recipients
Endpoint domain: Mortality/survival
Primary endpoint: Change in Skin Tissue Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change From Baseline in HbA1C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in office blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Altered Electrocortical Patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change From Baseline in Short Term Memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: DNMT1 protein level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in safety laboratory measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of training programme
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Fluid status (net gain vs net loss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-related quality of life changes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total Opioid-consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Neuropsychological testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Patients Reporting Dose-Limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Best Response to Dose Level 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical assessment of the rash
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Photometric test of sebum exertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: GIR 0-12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post Caesarean Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparison of SARS-COV2 PCR test and PCL rapid antigen test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes